A team of researchers at UCLA have discovered a combination of drugs to prevent the growth of glioblastomas, as well as kill tumour cells in mice with glioblastomas

Jonathan Canty, our Project Information Analyst, reflects on the SNP Conference in Glasgow last week

A research team at the University of Texas, led by Professor George Biros have been able to accurately characterise gliomas using a super computer

Professor Frank Winkler and his team at Heidelberg University in Germany have discovered a potential mechanism that could explain glioma recurrence

Our Policy & Public Affairs Manager Cameron Miller, reports from the Conservative Party Conference.

We were delighted to bring together a number of representatives from our incredible corporate partners to use their expertise to help us in our mission of defeating brain tumours.

Researchers at The Institute of Cancer Research identify new subgroups for high-grade glial tumours occurring in children

Our Policy & Public Affairs Manager, Cameron Miller, writes from the frontline of the party conference in Brighton

Researchers at Stanford University discover that the absence of a particular protein halts the growth of high-grade gliomas

A diffuse intrinsic pontine glioma (DIPG) diagnosis can be one of the most difficult things for a parent to hear, leaving families feeling helpless and desperately frustrated with the devastating prognosis.

Sarah Lindsell, The Charity’s Chief Executive, has co-signed a letter urging the Secretary of State for Health, Jeremy Hunt, to protect England’s largest annual survey of cancer patient experience in the NHS

We have awarded the Dutch/British WINDOW Consortium a grant of £1.5 million (€1.75 million) for research into Glioblastoma

A team of researchers investigated the effect of the Zika virus on glioblastoma cells in mice, as well as in human brain tissue samples. They discovered that the virus infected and killed the cancerous cells

Sarah Lindsell, our CEO, talks about why gifts in Wills should be in our everyday conversations…

As part of our commitment to improving life today for those affected by brain tumours, we’re excited to announce the expansion of our support offering as we roll out Live Chat

Communications Officer, Stephanie Layton, explores the progress of some of the exciting research Dr Darren Hargrave is currently working on.

We believe brain tumour patients need a ‘global Britain’ after Brexit. The UK Government has published an important paper outlining its current position on scientific cooperation for when the UK leaves the European Union

HeadSmart were ‘all fired up’ after learning from Saturdays’ singer Rochelle Humes they had been voted the UK’s favourite National Lottery funded health project.

Researchers have barcoded cancer cells to learn more about growth patterns in hopes of developing more targeted treatments.

Yesterday the UK Government published the recommendations of an independent review of the UK Life Sciences industry

Six years ago, Martino Sclavi was given 18 months to live after a grade 4 glioblastoma brain tumour diagnosis. A side effect of his brain surgery left the film producer unable to read. Words had escaped him

This means that 1/2a clinical trials using the drug VBI-1901 can now begin later this year in patients with recurrent GBM. The trials will examine the safety and effectiveness of the drug

The brain tumour databank launches today. This ground breaking project will revolutionise the way brain tumour data is used worldwide

Thanks to your continued support and fundraising, we’re delighted to announce that we’ve been able to award over £3.8 million to five new exciting research initiatives across the globe